Canada markets closed

Santen Pharmaceutical Co., Ltd. (SNPHF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
10.09-0.28 (-2.72%)
At close: 09:49AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.77B
Enterprise Value 3.16B
Trailing P/E 21.97
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.94
Price/Book (mrq)1.89
Enterprise Value/Revenue 1.64
Enterprise Value/EBITDA 9.79

Trading Information

Stock Price History

Beta (5Y Monthly) 0.26
52-Week Change 35.21%
S&P500 52-Week Change 323.49%
52 Week High 310.60
52 Week Low 38.46
50-Day Moving Average 39.73
200-Day Moving Average 39.51

Share Statistics

Avg Vol (3 month) 385
Avg Vol (10 day) 320
Shares Outstanding 5363.21M
Implied Shares Outstanding 6373.35M
Float 8348.89M
% Held by Insiders 12.79%
% Held by Institutions 151.17%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.22
Forward Annual Dividend Yield 42.17%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 42.11
Payout Ratio 445.60%
Dividend Date 3Jun 27, 2018
Ex-Dividend Date 4Sept 27, 2024
Last Split Factor 25:1
Last Split Date 3Mar 27, 2015

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 8.82%
Operating Margin (ttm)3.01%

Management Effectiveness

Return on Assets (ttm)5.62%
Return on Equity (ttm)8.92%

Income Statement

Revenue (ttm)301.96B
Revenue Per Share (ttm)823.04
Quarterly Revenue Growth (yoy)-0.20%
Gross Profit (ttm)N/A
EBITDA 56.72B
Net Income Avi to Common (ttm)26.64B
Diluted EPS (ttm)0.46
Quarterly Earnings Growth (yoy)-97.40%

Balance Sheet

Total Cash (mrq)94.96B
Total Cash Per Share (mrq)261.62
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.55
Book Value Per Share (mrq)843.19

Cash Flow Statement

Operating Cash Flow (ttm)72.65B
Levered Free Cash Flow (ttm)50.53B